Player FM ऐप के साथ ऑफ़लाइन जाएं!
Dec 13 2024 This Week in Cardiology
Manage episode 455347896 series 2794872
US doc's pay, the ticagrelor controversy and new RCTs, clopidogrel beats ASA, holding antiplatelets for non-cardiac surgery, and Prof Cleland and ASA dogma are the topics John Mandrola, MD, covers this week.
This podcast is intended for healthcare professionals only.
To read a partial transcript or to comment, visit:
https://www.medscape.com/twic
I. US Healthcare
Mandrola’s Top 10 Stories in 2024 https://www.medscape.com/viewarticle/mandrolas-top-10-stories-2024-2024a1000mxe?_gl=1*dcvmkh*_gcl_au*MTgzOTY2ODQ0Ni4xNzI5MjU4NjUz
- CMS Proposal
II. Ticagrelor Controversy
New Investigation Casts Doubt on Landmark Ticagrelor Trial
- Doshi Review https://www.bmj.com/content/387/bmj.q2550
- PLATO https://www.nejm.org/doi/full/10.1056/NEJMoa0904327
- ISAR REACT 5 https://www.nejm.org/doi/full/10.1056/NEJMoa1908973
- Bates Review https://www.ahajournals.org/doi/epub/10.1161/JAHA.123.031606
- Victor Serebuany and Dan Atar Editorial https://doi.org/10.1093/eurheartj/ehp545
III. New Ticagrelor vs Clopdiogrel trial
IV. Clopidogrel Better Than ASA Even in HBR
- Substudy Long-Term Aspirin vs Clopidogrel After Coronary Stenting by Bleeding Risk and Procedural Complexity
- HOST-EXAM 10.1016/S0140-6736(21)01063-1
- HOST-EXAM-Extended https://doi.org/10.1161/CIRCULATIONAHA.122.062770
V. ASA During Non-Cardiac Surgery
- ASSURE DES https://doi.org/10.1016/j.jacc.2024.08.024
VII. Professor Cleland on ASA for Secondary Prevention
- Cleland Editorial https//jamanetwork.com/journals/jamacardiology/article-abstract/2827201
- ASA Meta-analysis 10.1016/S0140-6736(09)60503-1
- AMIS https://jamanetwork.com/journals/jama/fullarticle/368745
- SAPAT 10.1016/0140-6736(92)92619-Q
You may also like:
The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington
Questions or feedback, please contact [email protected]
347 एपिसोडस
Manage episode 455347896 series 2794872
US doc's pay, the ticagrelor controversy and new RCTs, clopidogrel beats ASA, holding antiplatelets for non-cardiac surgery, and Prof Cleland and ASA dogma are the topics John Mandrola, MD, covers this week.
This podcast is intended for healthcare professionals only.
To read a partial transcript or to comment, visit:
https://www.medscape.com/twic
I. US Healthcare
Mandrola’s Top 10 Stories in 2024 https://www.medscape.com/viewarticle/mandrolas-top-10-stories-2024-2024a1000mxe?_gl=1*dcvmkh*_gcl_au*MTgzOTY2ODQ0Ni4xNzI5MjU4NjUz
- CMS Proposal
II. Ticagrelor Controversy
New Investigation Casts Doubt on Landmark Ticagrelor Trial
- Doshi Review https://www.bmj.com/content/387/bmj.q2550
- PLATO https://www.nejm.org/doi/full/10.1056/NEJMoa0904327
- ISAR REACT 5 https://www.nejm.org/doi/full/10.1056/NEJMoa1908973
- Bates Review https://www.ahajournals.org/doi/epub/10.1161/JAHA.123.031606
- Victor Serebuany and Dan Atar Editorial https://doi.org/10.1093/eurheartj/ehp545
III. New Ticagrelor vs Clopdiogrel trial
IV. Clopidogrel Better Than ASA Even in HBR
- Substudy Long-Term Aspirin vs Clopidogrel After Coronary Stenting by Bleeding Risk and Procedural Complexity
- HOST-EXAM 10.1016/S0140-6736(21)01063-1
- HOST-EXAM-Extended https://doi.org/10.1161/CIRCULATIONAHA.122.062770
V. ASA During Non-Cardiac Surgery
- ASSURE DES https://doi.org/10.1016/j.jacc.2024.08.024
VII. Professor Cleland on ASA for Secondary Prevention
- Cleland Editorial https//jamanetwork.com/journals/jamacardiology/article-abstract/2827201
- ASA Meta-analysis 10.1016/S0140-6736(09)60503-1
- AMIS https://jamanetwork.com/journals/jama/fullarticle/368745
- SAPAT 10.1016/0140-6736(92)92619-Q
You may also like:
The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington
Questions or feedback, please contact [email protected]
347 एपिसोडस
Semua episod
×प्लेयर एफएम में आपका स्वागत है!
प्लेयर एफएम वेब को स्कैन कर रहा है उच्च गुणवत्ता वाले पॉडकास्ट आप के आनंद लेंने के लिए अभी। यह सबसे अच्छा पॉडकास्ट एप्प है और यह Android, iPhone और वेब पर काम करता है। उपकरणों में सदस्यता को सिंक करने के लिए साइनअप करें।